Logo image of BHM

BLUEROCK HOMES TRUST INC (BHM) Stock Fundamental Analysis

NYSEARCA:BHM - NYSE Arca - US09631H1005 - REIT - Currency: USD

10.2404  +0.03 (+0.3%)

Fundamental Rating

2

Overall BHM gets a fundamental rating of 2 out of 10. We evaluated BHM against 20 industry peers in the Residential REITs industry. BHM scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. BHM is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year BHM has reported negative net income.
BHM had a positive operating cash flow in the past year.
BHM Yearly Net Income VS EBIT VS OCF VS FCFBHM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 0 100M -100M -200M

1.2 Ratios

With a Return On Assets value of -0.41%, BHM is not doing good in the industry: 65.00% of the companies in the same industry are doing better.
Looking at the Return On Equity, with a value of -1.44%, BHM is doing worse than 70.00% of the companies in the same industry.
Industry RankSector Rank
ROA -0.41%
ROE -1.44%
ROIC N/A
ROA(3y)5.89%
ROA(5y)N/A
ROE(3y)6.41%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BHM Yearly ROA, ROE, ROICBHM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 10 20

1.3 Margins

BHM has a Gross Margin of 42.65%. This is amonst the worse of the industry: BHM underperforms 95.00% of its industry peers.
BHM's Gross Margin has declined in the last couple of years.
BHM does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 42.65%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-21.12%
GM growth 5YN/A
BHM Yearly Profit, Operating, Gross MarginsBHM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 0 200 -200 400 600

More info and screens

4

2. Health

2.1 Basic Checks

BHM does not have a ROIC to compare to the WACC, probably because it is not profitable.
BHM has more shares outstanding than it did 1 year ago.
Compared to 1 year ago, BHM has a worse debt to assets ratio.
BHM Yearly Shares OutstandingBHM Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 1M 2M 3M
BHM Yearly Total Debt VS Total AssetsBHM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 200M 400M 600M

2.2 Solvency

BHM has an Altman-Z score of 0.29. This is a bad value and indicates that BHM is not financially healthy and even has some risk of bankruptcy.
BHM's Altman-Z score of 0.29 is on the low side compared to the rest of the industry. BHM is outperformed by 75.00% of its industry peers.
A Debt/Equity ratio of 0.90 indicates that BHM is somewhat dependend on debt financing.
BHM has a Debt to Equity ratio (0.90) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.9
Debt/FCF N/A
Altman-Z 0.29
ROIC/WACCN/A
WACC6.01%
BHM Yearly LT Debt VS Equity VS FCFBHM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 0 200M -200M 400M

2.3 Liquidity

BHM has a Current Ratio of 4.86. This indicates that BHM is financially healthy and has no problem in meeting its short term obligations.
BHM's Current ratio of 4.86 is amongst the best of the industry. BHM outperforms 100.00% of its industry peers.
A Quick Ratio of 4.86 indicates that BHM has no problem at all paying its short term obligations.
BHM's Quick ratio of 4.86 is amongst the best of the industry. BHM outperforms 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 4.86
Quick Ratio 4.86
BHM Yearly Current Assets VS Current LiabilitesBHM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 20M 40M 60M 80M 100M

More info and screens

3

3. Growth

3.1 Past

BHM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 17.67%, which is quite good.
BHM shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 16.37%.
The Revenue has been growing by 77.33% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)17.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%184.96%
Revenue 1Y (TTM)16.37%
Revenue growth 3Y77.33%
Revenue growth 5YN/A
Sales Q2Q%24.81%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BHM Yearly Revenue VS EstimatesBHM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 10M 20M 30M 40M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

BHM reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BHM Price Earnings VS Forward Price EarningsBHM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

BHM's Enterprise Value to EBITDA ratio is rather expensive when compared to the industry. BHM is more expensive than 95.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 39.48
BHM Per share dataBHM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

3

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 4.96%, BHM is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 4.51, BHM pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.44, BHM pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.96%

5.2 History

BHM is new to the dividend game and has less than 3 years of track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
BHM Yearly Dividends per shareBHM Yearly Dividends per shareYearly Dividends per share 2023 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

BHM has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-172.84%
EPS Next 2YN/A
EPS Next 3YN/A
BHM Yearly Income VS Free CF VS DividendBHM Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2020 2021 2022 2023 0 100M -100M -200M

More info and screens

BLUEROCK HOMES TRUST INC

NYSEARCA:BHM (5/2/2025, 8:04:01 PM)

10.2404

+0.03 (+0.3%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryResidential REITs
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners35.26%
Inst Owner ChangeN/A
Ins Owners9.37%
Ins Owner Change0%
Market Cap39.84M
AnalystsN/A
Price TargetN/A
Short Float %0.27%
Short Ratio1.69
Dividend
Industry RankSector Rank
Dividend Yield 4.96%
Yearly Dividend0.02
Dividend Growth(5Y)N/A
DP-172.84%
Div Incr Years0
Div Non Decr Years0
Ex-Date12-24 2025-12-24 (0.125)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.85
P/FCF N/A
P/OCF 3.57
P/B 0.17
P/tB 0.17
EV/EBITDA 39.48
EPS(TTM)-0.86
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-14.16
FCFYN/A
OCF(TTM)2.86
OCFY27.98%
SpS12.06
BVpS58.85
TBVpS58.72
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.41%
ROE -1.44%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 42.65%
FCFM N/A
ROA(3y)5.89%
ROA(5y)N/A
ROE(3y)6.41%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-21.12%
GM growth 5YN/A
F-Score3
Asset Turnover0.06
Health
Industry RankSector Rank
Debt/Equity 0.9
Debt/FCF N/A
Debt/EBITDA 72.93
Cap/Depr 334.93%
Cap/Sales 141.2%
Interest Coverage N/A
Cash Conversion 392.39%
Profit Quality N/A
Current Ratio 4.86
Quick Ratio 4.86
Altman-Z 0.29
F-Score3
WACC6.01%
ROIC/WACCN/A
Cap/Depr(3y)1202.97%
Cap/Depr(5y)N/A
Cap/Sales(3y)764.82%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)17.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%184.96%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)16.37%
Revenue growth 3Y77.33%
Revenue growth 5YN/A
Sales Q2Q%24.81%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-22.54%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y79.2%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-28.93%
OCF growth 3Y-1.64%
OCF growth 5YN/A